EGenesis logo

EGenesis

Cambridge, MA

eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells.

egenesisbio.com

Company Details

Founded

2015

Employees

Between 10 - 200 employees

Raised

$456,000,000

Headquarters Location

Cambridge, MA

Public

No

Acquired

No

CEO

Mike CurtisMike Curtis

Founders

Luhan Yang
Luhan Yang
Geoff Mackay
Geoff Mackay
George Church
George Church

Company Collections

These are collections EGenesis is a part of. Click on the collection name to view similar companies.

EGenesis' Investors

EGenesis' Industries

EGenesis' Tech Stack

EGenesis Headquarters Location

300 Technology Square, Cambridge, MA 02139

Total Amount Raised: $456,000,000

EGenesis' Investors

EGenesis Funding Rounds

  • Series D

    $191,000,000

    Series D Investors

    Lux Capital
    Farallon Capital Management
    Alta Partners
    Arch Venture Partners
    Khosla Ventures
    Leaps by Bayer
    Natco Pharma
    DaVita
    Fresenius Medical Care North America
    Parkwood
    Eisai Innovation

  • Series C

    $125,000,000

    Series C Investors

    Irving Investors
    LifeSci Venture Partners
    Monashee Investment Management
    OUP (Osage University Partners)
    Farallon Capital Management
    Altium Capital
    Samsara BioCapital
    SymBiosis
    Polaris Partners
    HBM Healthcare Investments
    Fresenius Medical Care North America
    Leaps by Bayer
    Khosla Ventures
    Wellington Partners
    Catalio Capital Management
    Arch Venture Partners
    Invus Group
    Alta Partners

  • Series B

    $100,000,000

    Series B Investors

    Fresenius Medical Care North America
    Khosla Ventures
    Biomatics Capital Partners
    Wellington Partners
    Leaps by Bayer
    Alta Partners
    Arch Venture Partners

  • Series A

    $38,000,000

    Series A Investors

    Arch Venture Partners
    Biomatics Capital Partners
    Khosla Ventures
    Alta Partners
    Alexandria Real Estate Equities
    Heritage Provider Network
    Berggruen Holdings
    Uprising
    Fan Ventures
    JDRF T1D Fund
    E Squared Capital Management

  • Convertible Note

    $2,000,000

Funding info provided by Diffbot.

EGenesis Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on EGenesis.

Recent reviews